Sildenafil can be a strong and selective inhibitor of cGMP-distinct phosphodiesterase kind five (PDE5), and that is accountable for degradation of cGMP from the corpus cavernosum. The molecular construction of sildenafil is analogous to that of cGMP and functions as being a competitive binding agent of PDE5 inside the corpus cavernosum, leading to